Status:
NOT_YET_RECRUITING
Dual-focus Soft Contact Lenses for Controlling Rapid Progressive Myopia in Young Adults
Lead Sponsor:
Shanghai Eye Disease Prevention and Treatment Center
Conditions:
Myopia
Eligibility:
All Genders
18-25 years
Phase:
NA
Brief Summary
This study aims to evaluate the effectiveness and acceptability of dual-focus soft contact lenses in controlling rapid myopia progression in adults through a randomized controlled trial. By applying m...
Detailed Description
It has long been believed that the progression of myopia mainly occurs during the elementary to high school stages. However, some studies and clinical practice suggest that a considerable proportion o...
Eligibility Criteria
Inclusion
- Age 18-25 years;
- Myopia progression \<= -0.50D in either eye in the past year (evaluated by -manifest refraction);
- The subject eye: cycloplegic spherical equivalent ranges from -2.00D to -6.0D and cylinder power doesn't exceed -1.50D;
- The subject eye's best corrected visual acuity \<= logMAR 0.1;
- Anisometropia does not exceed 1.50D.
Exclusion
- Current use of MC interventions or prior use of MC interventions within the past 6 months;
- Disease or anatomical factors that affect the wearing of contact lenses;
- History of myopia correction surgery;
- Suffering from ocular or systemic diseases that may be related to myopia, such as Marfan syndrome, retinopathy of prematurity, diabetes, etc.;
- pregnant female;
- Other conditions deemed unsuitable by the investigators.
Key Trial Info
Start Date :
August 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT06528860
Start Date
August 31 2024
End Date
September 30 2027
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Eye Disease Prevention & Treatment Center
Shanghai, Shanghai Municipality, China, 200041